| Name | PF-04634817 succinate |
|---|
| Description | PF-04634817 is a potent, orally bioavailble CCR2 and CCR5 chemokine receptor antagonist, for the treatment of diabetic nephropathies and diabetic macular oedema. Other Indication Phase 2 Discontinued |
|---|---|
| References | References View Related Products by Target Chemokine Receptor (CCR and CXCR) Other Indication |
| Molecular Formula | C25H36F3N5O3·C4H6O4 |
|---|---|
| Molecular Weight | 629.67 |